Defendants have a history of violating the act,” the complaint said. “Several of the dietary supplement cGMP deviations observed during the July 2013 inspection ... are the same as, or similar to, those observed by FDA during inspections of defendants’ facility between March 13-23, 2012, and between March 18-22, 2013.
Here's the FDA action versus Mira. More later.